Filter
538
Text search:
experimental
drug
Featured
Recommendations
43
New Publications
96
Language
Document type
No document type
312
Studies & Reports
93
Guidelines
71
Manuals
28
Strategic & Response Plan
11
Training Material
7
Fact sheets
7
Situation Updates
5
Resource Platforms
4
Countries / Regions
India
26
Global
18
Western and Central Europe
16
Latin America and the Carribbean
12
Kenya
11
Ethiopia
9
Rwanda
9
South Africa
9
Sierra Leone
7
Uganda
6
Ukraine
6
Liberia
5
Nigeria
5
Germany
5
Tanzania
5
Bangladesh
5
Brazil
5
Eastern Europe
5
Ghana
4
Zimbabwe
4
Nepal
4
South Sudan
4
Africa
4
Russia
4
Congo, Democratic Republic of
3
USA
3
Philippines
3
Malawi
3
Argentina
3
Colombia
3
Myanmar / Burma
3
West and Central Africa
3
Middle East and North Africa
3
South–East Asia Region
3
Burkina Faso
2
Senegal
2
Cameroon
2
Haiti
2
Zambia
2
Indonesia
2
Eswatini/ Swaziland
2
Lesotho
2
Eastern Europe and Central Asia
2
Venezuela
2
Tajikistan
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Syria
1
Thailand
1
China
1
Mozambique
1
Namibia
1
Peru
1
Botswana
1
Yemen
1
East and Southern Africa
1
Paraguay
1
Asia
1
Canada
1
Uzbekistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
134
Clinical Guidelines
60
Public Health
36
Women & Child Health
12
Key Resources
11
Capacity Building
6
Pharmacy & Technologies
6
Toolboxes
Mental Health
97
TB
43
HIV
38
COVID-19
38
Ebola
32
NTDs
30
Rapid Response
27
Pharmacy
21
AMR
19
Caregiver
15
Planetary Health
12
NCDs
11
Disability
10
Global Health Education
6
Zika
4
Conflict
3
Refugee
3
Health Financing Toolbox
3
Natural Hazards
2
Specific Hazards
2
Cholera
1
This clinical management manual for Ebola Viral Disease in Liberia was developed after several ETUs were established in the country following the outbreak early this year. As the outbreak evolved, it became evident that different SOPs were being used by clinicians across these treatment facilities.
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
The BBV/STI Glossary is a resource for interpreters, translators and others who work in a health setting. It offers an extensive list of English terms related to sexual health and blood-borne viruses (such as hepatitis), with easy to understand definitions.
Accessed 13th of November 2015.
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
The threat posed by Zika virus infection highlights the need to reinforce preparedness arrangements for mosquito-borne diseases in EU/EEA countries, especially for pathogens transmitted by Aedes aegypti and Aedes albopictus.
The aim of this document is to highlight measures that can effectively red
...
This guidance provides an overview of interventions to improve early diagnosis of TB and treatment completion in these populations, as well as factors to consider when developing programmes for health communication, awareness and education, and programme monitoring and evaluation
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries
Guidelines for the Prevention of Cardiovascular Disease in Women in Indonesia
District Level M & E Training and Reference Material for Primary Health Care Programmes
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
